| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | 0.078 | 0.04 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.04 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.078 | 0.04 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.04 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | -0.066 | 0.04 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.065 | 0.04 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | 0.3 | 0.05 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.061 | 0.05 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.05 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | -0.058 | 0.05 |